The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Gemcitabine and cisplatin plus ramucirumab or merestinib or placebo in first-line treatment for advanced or metastatic biliary tract cancer: A double-blind, randomized phase II trial.
 
Ashwin Reddy Sama
Honoraria - Bayer; OncoPlex Diagnostics
Research Funding - Bristol-Myers Squibb (Inst); Incyte (Inst); Lilly; MedImmune (Inst); OncoMed (Inst); Precision Biologics (Inst)
Travel, Accommodations, Expenses - Celgene
 
Crystal Shereen Denlinger
Consulting or Advisory Role - Lilly; Merrimack
Research Funding - Astex Pharmaceuticals (Inst); Genentech/Roche (Inst); Incyte (Inst); Lilly (Inst); MedImmune (Inst); Merrimack (Inst); OncoMed (Inst); Pfizer (Inst)
 
Arndt Vogel
Consulting or Advisory Role - Lilly
 
Aiwu Ruth He
No Relationships to Disclose
 
Nathalie Bousmans
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Wei Zhang
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Richard A. Walgren
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Juan W. Valle
Honoraria - Advanced Accelerator Applications; AstraZeneca; Baxalta; Celgene; Ipsen; Lilly; Merck; Midatech Pharma; Novartis; Sirtex Medical
Consulting or Advisory Role - Advanced Accelerator Applications; AstraZeneca; Baxalta; Celgene; Ipsen; Lilly; Merck; Novartis; Sirtex Medical
Speakers' Bureau - Abbott Nutrition; Celgene; Ipsen; Novartis; Pfizer; Sirtex Medical
Research Funding - AstraZeneca (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis